Berkowitz v. Boehringer Ingelheim Pharmaceuticals, Inc.
Plaintiff / Appellee: Jerome Jay Berkowitz
Defendant / Appellant: Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi-Aventis U.S. LLC and Sanofi US Services Inc.
Case Number: 23-878
Filed: June 13, 2023
Court: U.S. Court of Appeals, Second Circuit
Nature of Suit: Torts
Docket Report

This docket was last retrieved on July 18, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
July 18, 2023 Filing 74 CURED DEFECTIVE JOINT APPENDIX, volumes 1-5, [ # 67 ], [ # 68 ], [ # 69 ], [ # 70 ], [ # 71 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543230] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:46 PM]
July 18, 2023 Filing 73 CURED DEFECTIVE BRIEF & SPECIAL APPENDIX, [ # 66 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543227] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:44 PM]
July 18, 2023 Filing 72 MOTION ORDER, granting motion to adjourn oral argument [ # 63 ] filed by Appellant Sanofi-Aventis U.S. LLC and Sanofi US Services Inc. in 23-877, FILED. [3543211][72] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:35 PM]
July 18, 2023 Filing 71 JOINT APPENDIX, volume 5 of 5, (pp. 1036-1307), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543205] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:30 PM]
July 18, 2023 Filing 70 JOINT APPENDIX, volume 4 of 5, (pp. 780-1035), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543199] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:28 PM]
July 18, 2023 Filing 69 JOINT APPENDIX, volume 3 of 5, (pp. 530-779), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543196] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:24 PM]
July 18, 2023 Filing 68 JOINT APPENDIX, volume 2 of 5, (pp. 261-529), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543192] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:21 PM]
July 18, 2023 Filing 67 JOINT APPENDIX, volume 1 of 5, (pp. 1-260), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543189] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:19 PM]
July 18, 2023 Filing 66 BRIEF & SPECIAL APPENDIX, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF. [3543185] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:15 PM]
July 18, 2023 Filing 64 CURED DEFECTIVE MOTION, TO ADJOURN ORAL ARGUMENT, [ # 63 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543083] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 12:56 PM]
July 18, 2023 Filing 63 MOTION, to adjourn oral argument, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF. [3543073] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 12:52 PM]
July 18, 2023 Filing 59 DEFECTIVE DOCUMENT, Joint Appendix, volumes 1-5, [50], [51], [52], [53], [54], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542873] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 09:17 AM]
July 18, 2023 Filing 58 DEFECTIVE DOCUMENT, Brief & Special Appendix, [49], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542867] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 09:06 AM]
July 18, 2023 Filing 57 DEFECTIVE DOCUMENT, MOTION, to adjourn oral argument, [55], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542842] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 08:43 AM]
July 17, 2023 Filing 55 MOTION, to adjourn oral argument, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF. [3542754] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885]--[Edited 07/18/2023 by RW] [Entered: 07/17/2023 08:06 PM]
July 17, 2023 Filing 54 JOINT APPENDIX, volume 5 of 5, (pp. 1036-1307), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542747] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:19 PM]
July 17, 2023 Filing 53 JOINT APPENDIX, volume 4 of 5, (pp. 780-1035), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542746] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:15 PM]
July 17, 2023 Filing 52 JOINT APPENDIX, volume 3 of 5, (pp. 530-779), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542745] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:13 PM]
July 17, 2023 Filing 51 JOINT APPENDIX, volume 2 of 5, (pp. 261-529), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542744] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:10 PM]
July 17, 2023 Filing 50 JOINT APPENDIX, volume 1 of 5, (pp. 1-260), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542743] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:08 PM]
July 17, 2023 Filing 49 BRIEF & SPECIAL APPENDIX, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF. [3542742] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:05 PM]
July 14, 2023 Filing 45 ATTORNEY, James I. Glasser for Pfizer, Inc., in case 23-878 , [ # 22 ], ADDED.[3541453] [23-878] [Entered: 07/14/2023 09:39 AM]
July 14, 2023 Filing 44 NEW CASE MANAGER, Ronald Willoughby, ASSIGNED.[3541402] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/14/2023 08:45 AM]
July 13, 2023 Filing 35 ATTORNEY, Robert A. Izard Jr. for Jerome Jay Berkowitz, in case 23-878, [ # 32 ], ADDED.[3541191] [23-878] [Entered: 07/13/2023 04:37 PM]
July 11, 2023 Filing 33 CURED DEFECTIVE Notice of Appearance as Additional Counsel, [ # 28 ], [ # 30 ], on behalf of Appellee Jerome Jay Berkowitz, FILED.[3539791] [23-878] [Entered: 07/11/2023 12:21 PM]
July 5, 2023 Filing 32 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Jerome Jay Berkowitz, FILED. Service date 07/05/2023 by CM/ECF. [3537352] [23-878] [Entered: 07/05/2023 04:08 PM]
July 5, 2023 Filing 30 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Jerome Jay Berkowitz, FILED. Service date 07/05/2023 by CM/ECF. [3537253] [23-878] [Entered: 07/05/2023 02:54 PM]
July 5, 2023 Filing 29 DEFECTIVE DOCUMENT, Notice of Appearance as Additional Counsel, [ # 26 ], on behalf of Appellee Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED.[3537032] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/05/2023 11:21 AM]
July 5, 2023 Filing 28 DEFECTIVE DOCUMENT, Notice of Appearance as Additional Counsel, [ # 25 ], on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, FILED.[3537005] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/05/2023 11:09 AM]
June 30, 2023 Filing 27 ATTORNEY, Jaime Ashley Welsh for Boehringer Ingelheim Corporation Boehringer Ingelheim USA Corporation Boehringer Ingelheim Pharmaceuticals, Inc., in case 23-878, [ # 23 ], ADDED.[3536379] [23-878] [Entered: 06/30/2023 12:50 PM]
June 29, 2023 Filing 26 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED. Service date 06/29/2023 by CM/ECF. [3535620] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/29/2023 12:04 PM]
June 29, 2023 Filing 25 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED. Service date 06/29/2023 by CM/ECF. [3535610] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/29/2023 11:49 AM]
June 28, 2023 Filing 24 ELECTRONIC INDEX, in lieu of record, FILED.[3535332] [23-878] [Entered: 06/28/2023 08:42 PM]
June 28, 2023 Filing 23 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/28/2023 by CM/ECF. [3535086] [23-878] [Entered: 06/28/2023 03:07 PM]
June 27, 2023 Filing 22 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF. [3534547] [23-878] [Entered: 06/27/2023 05:07 PM]
June 27, 2023 Filing 21 FORM D, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534530] [23-878] [Entered: 06/27/2023 04:53 PM]
June 27, 2023 Filing 20 FORM C, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534524] [23-878] [Entered: 06/27/2023 04:51 PM]
June 27, 2023 Filing 19 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534520] [23-878] [Entered: 06/27/2023 04:50 PM]
June 27, 2023 Filing 18 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellee Jerome Jay Berkowitz, FILED. Service date 06/27/2023 by CM/ECF, email.[3534497] [23-878] [Entered: 06/27/2023 04:37 PM]
June 27, 2023 Filing 17 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534436] [23-878] [Entered: 06/27/2023 04:00 PM]
June 27, 2023 Filing 16 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534398] [23-878] [Entered: 06/27/2023 03:34 PM]
June 27, 2023 Filing 15 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534337] [23-878] [Entered: 06/27/2023 02:21 PM]
June 27, 2023 Filing 14 FORM D, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534331] [23-878] [Entered: 06/27/2023 02:17 PM]
June 27, 2023 Filing 13 FORM D, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534328] [23-878] [Entered: 06/27/2023 02:15 PM]
June 27, 2023 Filing 12 FORM C, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534326] [23-878] [Entered: 06/27/2023 02:14 PM]
June 27, 2023 Filing 11 FORM C, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534321] [23-878] [Entered: 06/27/2023 02:13 PM]
June 27, 2023 Filing 10 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534319] [23-878] [Entered: 06/27/2023 02:11 PM]
June 27, 2023 Filing 9 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534308] [23-878] [Entered: 06/27/2023 02:09 PM]
June 27, 2023 Filing 8 FORM D, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534282] [23-878] [Entered: 06/27/2023 01:59 PM]
June 27, 2023 Filing 7 FORM C, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534280] [23-878] [Entered: 06/27/2023 01:58 PM]
June 27, 2023 Filing 6 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534278] [23-878] [Entered: 06/27/2023 01:58 PM]
June 27, 2023 Filing 5 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534243] [23-878] [Entered: 06/27/2023 01:33 PM]
June 20, 2023 Filing 4 CASE CALENDARING, for the week of 09/18/2023, A, PROPOSED.[3531137] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/20/2023 01:10 PM]
June 16, 2023 Opinion or Order Filing 3 ORDER, dated 06/16/2023, setting Appellant's brief due date as July 17, 2023 and Appellees' brief due date as August 17, 2023. The reply brief is due by August 28, 2023. The Clerk is directed to set the appeal for argument as early as the week of September 18, 2023., FILED.[3530582] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/16/2023 04:28 PM]
June 13, 2023 Filing 2 DISTRICT COURT ORDER, entered in the district court as docket entry dated 01/17/2023, RECEIVED.[3528540] [23-878] [Entered: 06/13/2023 01:11 PM]
June 13, 2023 Filing 1 NOTICE OF CIVIL APPEAL, with district court docket, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. [3528534] [23-878] [Entered: 06/13/2023 01:05 PM]

Access additional case information on PACER

Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Search for this case: Berkowitz v. Boehringer Ingelheim Pharmaceuticals, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff / appellee: Jerome Jay Berkowitz
Represented By: John Bruegger Esq.
Represented By: Craig Archer Raabe Esq.
Represented By: Robert A. Izard Esq. Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Boehringer Ingelheim Pharmaceuticals, Inc.
Represented By: Patrick M. Fahey Esq.
Represented By: Jaime Ashley Welsh Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Boehringer Ingelheim Corporation
Represented By: Patrick M. Fahey Esq.
Represented By: Jaime Ashley Welsh Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Boehringer Ingelheim USA Corporation
Represented By: Patrick M. Fahey Esq.
Represented By: Jaime Ashley Welsh Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: GlaxoSmithKline LLC
Represented By: Lindsey Cohan Esq.
Represented By: Robert R. Simpson Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Glaxosmithkline Holdings (Americas), Inc.
Represented By: Lindsey Cohan Esq.
Represented By: Robert R. Simpson Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Pfizer, Inc.
Represented By: James O. Craven Esq.
Represented By: James I. Glasser
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Sanofi-Aventis U.S. LLC
Represented By: Anand Agneshwar Esq.
Represented By: Joseph W. Martini
Represented By: Daniel S. Pariser Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: Sanofi US Services Inc.
Represented By: Anand Agneshwar Esq.
Represented By: Joseph W. Martini
Represented By: Daniel S. Pariser Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?